India 
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
Switzerland
-
June 19, 2023
India’s biosimilars industry staring at plethora of opportunities – Dr Cyrus Karkaria’s article in the Bio Voice .
-
June 6, 2023
Regulatory scrutiny and pricing pressure is reducing profitability – Ramesh Swaminathan, Executive Director, Global CFO, and Head Corporate Affairs, Lupin in an Industry Story, Published in Fortune India.
-
May 10, 2023
Vinita Gupta, CEO, Nilesh Gupta, MD and Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs, Lupin, with ET Now on the Q4 FY23 earnings
-
May 10, 2023
Vinita Gupta, CEO, Nilesh Gupta, MD and Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs, Lupin, with CNBC TV18 on the Q4 FY23 Earnings
-
May 10, 2023
Mr. Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs, Lupin on CNBC International – Q4 FY2023 Earnings
-
May 10, 2023
Ramesh Swaminathan, ED, Global CFO and Head Corporate Affairs with BQ Prime on the Q4 FY23 Earnings
-
April 9, 2023
Know-it-all bosses make way for ‘learning’ leaders – Yashwant Mahadik, Head Global HR, Lupin, in an Industry Story Published on April 2023, Times of India.
-
April 9, 2023
World Health Day: Program conducted by Lupin Human Welfare and Research Foundation – Published on April 2023, Prahar (Marathi).
-
April 7, 2023
Towards a TB-free India – Nilesh D. Gupta , Managing director, Lupin Ltd. , Published on April 2023, Financial Express.
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications